HOWE & RUSLING INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
HOWE & RUSLING INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$132,000
-38.9%
1,731
-32.2%
0.02%
-33.3%
Q2 2022$216,000
+157.1%
2,554
+167.7%
0.03%
+170.0%
Q1 2022$84,000
+9.1%
954
+7.9%
0.01%
+11.1%
Q4 2021$77,000
+16.7%
884
+9.0%
0.01%
+12.5%
Q3 2021$66,000
-10.8%
8110.0%0.01%
-11.1%
Q2 2021$74,000
+4.2%
811
-2.6%
0.01%
-10.0%
Q1 2021$71,000
-21.1%
833
-12.1%
0.01%
-28.6%
Q4 2020$90,000
-6.2%
948
-14.0%
0.01%
-12.5%
Q3 2020$96,000
+5.5%
1,102
+5.8%
0.02%
-5.9%
Q2 2020$91,000
+44.4%
1,042
+36.6%
0.02%
+21.4%
Q1 2020$63,000
-32.3%
763
-22.0%
0.01%
-6.7%
Q4 2019$93,000
+9.4%
9780.0%0.02%0.0%
Q3 2019$85,000
-7.6%
978
-2.5%
0.02%
-6.2%
Q2 2019$92,000
-39.9%
1,003
-37.1%
0.02%
-38.5%
Q1 2019$153,000
+3.4%
1,594
-7.3%
0.03%
-16.1%
Q4 2018$148,000
+0.7%
1,719
+0.8%
0.03%
+24.0%
Q3 2018$147,000
+72.9%
1,705
+50.9%
0.02%
+66.7%
Q2 2018$85,000
-22.7%
1,130
-16.6%
0.02%
-25.0%
Q1 2018$110,000
-14.7%
1,355
-11.6%
0.02%
-13.0%
Q4 2017$129,000
+1.6%
1,533
+3.9%
0.02%0.0%
Q3 2017$127,000
+13.4%
1,475
+10.0%
0.02%0.0%
Q2 2017$112,000
+12.0%
1,3410.0%0.02%
+15.0%
Q1 2017$100,000
+203.0%
1,341
+192.2%
0.02%
+185.7%
Q4 2016$33,000
-75.9%
459
-73.6%
0.01%
-76.7%
Q3 2016$137,000
-12.7%
1,741
-8.6%
0.03%
-14.3%
Q2 2016$157,000
+13.8%
1,9050.0%0.04%
+12.9%
Q1 2016$138,000
-9.8%
1,905
+7.1%
0.03%
-11.4%
Q4 2015$153,000
+13.3%
1,779
+21.5%
0.04%
+2.9%
Q3 2015$135,000
-6.2%
1,4640.0%0.03%
+9.7%
Q2 2015$144,0000.0%1,4640.0%0.03%
-3.1%
Q1 2015$144,000
-4.0%
1,464
-9.7%
0.03%
-11.1%
Q4 2014$150,000
-2.0%
1,6220.0%0.04%0.0%
Q3 2014$153,000
+4.1%
1,6220.0%0.04%
+9.1%
Q2 2014$147,000
-15.0%
1,622
-20.5%
0.03%
-21.4%
Q1 2014$173,000
+34.1%
2,039
+26.6%
0.04%
+31.2%
Q4 2013$129,000
-18.4%
1,610
-21.7%
0.03%
-44.8%
Q3 2013$158,000
+10.5%
2,056
+1.9%
0.06%
+45.0%
Q2 2013$143,0002,0170.04%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders